Published in J Card Fail on February 02, 2012
Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med (2012) 8.28
Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure. JACC Heart Fail (2014) 1.79
Targeting the kidney in acute heart failure: can old drugs provide new benefit? Renal Optimization Strategies Evaluation in Acute Heart Failure (ROSE AHF) trial. Circ Heart Fail (2013) 1.21
Contemporary strategies in the diagnosis and management of heart failure. Mayo Clin Proc (2014) 0.98
Cardiorenal [corrected] syndrome: an emerging problem in pediatric critical care. Pediatr Nephrol (2012) 0.81
Causes and treatment of oedema in patients with heart failure. Nat Rev Cardiol (2013) 0.78
Collaboration and entanglement: An actor-network theory analysis of team-based intraprofessional care for patients with advanced heart failure. Soc Sci Med (2016) 0.78
Treating volume overload in acutely decompensated heart failure: established and novel therapeutic approaches. Eur Heart J Acute Cardiovasc Care (2012) 0.78
Lack of concordance in defining worsening renal function by rise in creatinine vs rise in cystatin C. Congest Heart Fail (2013) 0.76
Serum Bicarbonate in Acute Heart Failure: Relationship to Treatment Strategies and Clinical Outcomes. J Card Fail (2016) 0.75
Approaches to decongestion in patients with acute decompensated heart failure. Curr Cardiol Rep (2013) 0.75
Trajectory of Congestion Metrics by Ejection Fraction in Patients With Acute Heart Failure (from the Heart Failure Network). Am J Cardiol (2017) 0.75
Impact of Ultrafiltration on Serum Sodium Homeostasis and its Clinical Implication in Patients With Acute Heart Failure, Congestion, and Worsening Renal Function. Circ Heart Fail (2017) 0.75
Timing and Causes of Readmission After Acute Heart Failure Hospitalization-Insights From the Heart Failure Network Trials. J Card Fail (2016) 0.75
Acute Kidney Injury in Pediatric Heart Failure. Curr Cardiol Rev (2016) 0.75
Extracorporeal Ultrafiltration for Fluid Overload in Heart Failure: Current Status and Prospects for Further Research. J Am Coll Cardiol (2017) 0.75
Effects of hypertonic saline solution on body weight and serum creatinine in patients with acute decompensated heart failure. World J Cardiol (2017) 0.75
Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med (2011) 11.99
Cardiorenal syndrome. J Am Coll Cardiol (2008) 7.09
Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol (2007) 6.12
Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol (2009) 5.76
Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol (2004) 4.14
Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival. Circulation (2010) 3.78
Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am Heart J (2004) 3.37
The cardiorenal syndrome: do we need a change of strategy or a change of tactics? J Am Coll Cardiol (2009) 2.09
Cardiorenal syndrome: new perspectives. Circulation (2010) 2.03
Secular trends in renal dysfunction and outcomes in hospitalized heart failure patients. J Card Fail (2006) 1.49
Raised venous pressure: a direct cause of renal sodium retention in oedema? Lancet (1988) 1.48
Circulatory response to fluid overload removal by extracorporeal ultrafiltration in refractory congestive heart failure. J Am Coll Cardiol (2001) 1.40
Apparent paradox of neurohumoral axis inhibition after body fluid volume depletion in patients with chronic congestive heart failure and water retention. Br Heart J (1994) 1.15
Sustained improvement in functional capacity after removal of body fluid with isolated ultrafiltration in chronic cardiac insufficiency: failure of furosemide to provide the same result. Am J Med (1994) 1.13
Contemporary trends in the pharmacological and extracorporeal management of heart failure: a nephrologic perspective. Circulation (2008) 1.06
Isolated ultrafiltration in moderate congestive heart failure. J Am Coll Cardiol (1993) 1.04
Peripherally inserted veno-venous ultrafiltration for rapid treatment of volume overloaded patients. J Card Fail (2003) 0.93
Loop diuretics can cause clinical natriuretic failure: a prescription for volume expansion. Congest Heart Fail (2009) 0.92
Selection of endpoints for heart failure clinical trials. Eur J Heart Fail (2003) 0.91
Extracorporeal ultrafiltration for the treatment of overhydration and congestive heart failure. Cardiology (2001) 0.82
The UNLOAD trial: a "nephrologic" standpoint. J Am Coll Cardiol (2007) 0.80
Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med (2005) 27.36
Bariatric surgery: a systematic review and meta-analysis. JAMA (2004) 23.34
Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med (2004) 19.42
Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med (2007) 17.85
Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med (2006) 17.13
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes. N Engl J Med (2015) 13.90
Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med (2011) 11.99
Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med (2014) 11.77
Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus. N Engl J Med (2013) 11.34
Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. N Engl J Med (2014) 10.54
Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med (2011) 10.29
Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial. JAMA (2004) 9.74
Angiotensin-converting-enzyme inhibition in stable coronary artery disease. N Engl J Med (2004) 9.67
C-reactive protein levels and outcomes after statin therapy. N Engl J Med (2005) 9.47
Cytochrome p-450 polymorphisms and response to clopidogrel. N Engl J Med (2008) 9.25
Trends in heart failure incidence and survival in a community-based population. JAMA (2004) 8.90
Outcomes of anatomical versus functional testing for coronary artery disease. N Engl J Med (2015) 8.70
Long-term use of ticagrelor in patients with prior myocardial infarction. N Engl J Med (2015) 8.69
Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med (2010) 8.28
Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med (2012) 8.28
Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA (2002) 8.28
Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis. JAMA (2011) 8.24
Coronary bypass surgery with or without surgical ventricular reconstruction. N Engl J Med (2009) 7.71
Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med (2013) 7.70
Rivaroxaban in patients with a recent acute coronary syndrome. N Engl J Med (2011) 7.30
Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med (2005) 6.86
Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials. JAMA (2005) 6.81
Myocardial viability and survival in ischemic left ventricular dysfunction. N Engl J Med (2011) 6.65
Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial. Lancet (2012) 6.42
Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA (2003) 6.39
HFSA 2010 Comprehensive Heart Failure Practice Guideline. J Card Fail (2010) 6.37
Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA (2009) 6.36
Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med (2008) 6.17
Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA (2005) 6.10
Systolic and diastolic heart failure in the community. JAMA (2006) 5.99
A sensitive cardiac troponin T assay in stable coronary artery disease. N Engl J Med (2009) 5.81
Effect of disodium EDTA chelation regimen on cardiovascular events in patients with previous myocardial infarction: the TACT randomized trial. JAMA (2013) 5.31
Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med (2005) 5.28
Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med (2008) 5.13
Home use of automated external defibrillators for sudden cardiac arrest. N Engl J Med (2008) 4.64
Association between performance measures and clinical outcomes for patients hospitalized with heart failure. JAMA (2007) 4.59
A tale of coronary artery disease and myocardial infarction. N Engl J Med (2012) 4.53
Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction. N Engl J Med (2015) 4.39
Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations. Am J Med (2013) 4.34
Quality of life with defibrillator therapy or amiodarone in heart failure. N Engl J Med (2008) 4.33
Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials. Lancet (2009) 4.31
Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA (2006) 4.30
Comparison of coding of heart failure and comorbidities in administrative and clinical data for use in outcomes research. Med Care (2005) 4.30
Music, imagery, touch, and prayer as adjuncts to interventional cardiac care: the Monitoring and Actualisation of Noetic Trainings (MANTRA) II randomised study. Lancet (2005) 4.29
Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study. J Am Coll Cardiol (2009) 4.16
Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy. J Am Coll Cardiol (2006) 4.16
Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol (2004) 4.14
Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome. N Engl J Med (2005) 4.13
Vorapaxar in the secondary prevention of atherothrombotic events. N Engl J Med (2012) 4.10
Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation (2003) 3.97
A standardized definition of ischemic cardiomyopathy for use in clinical research. J Am Coll Cardiol (2002) 3.97
Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry. J Am Coll Cardiol (2007) 3.92